高级搜索

血红蛋白水平对老年晚期非小细胞肺癌患者化疗预后的判断价值

杨丽菲, 余 敏, 丁振宇

杨丽菲, 余 敏, 丁振宇. 血红蛋白水平对老年晚期非小细胞肺癌患者化疗预后的判断价值[J]. 肿瘤防治研究, 2014, 41(05): 401-404. DOI: 10.3971/j.issn.1000-8578.2014.05.012
引用本文: 杨丽菲, 余 敏, 丁振宇. 血红蛋白水平对老年晚期非小细胞肺癌患者化疗预后的判断价值[J]. 肿瘤防治研究, 2014, 41(05): 401-404. DOI: 10.3971/j.issn.1000-8578.2014.05.012
YANG Lifei, YU Min, DING Zhenyu. Prognostic Value of Hemoglobin Level in Elderly Patients with Advanced Lung Cancer Treated with Chemotherapy[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 401-404. DOI: 10.3971/j.issn.1000-8578.2014.05.012
Citation: YANG Lifei, YU Min, DING Zhenyu. Prognostic Value of Hemoglobin Level in Elderly Patients with Advanced Lung Cancer Treated with Chemotherapy[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 401-404. DOI: 10.3971/j.issn.1000-8578.2014.05.012

血红蛋白水平对老年晚期非小细胞肺癌患者化疗预后的判断价值

基金项目: 国家自然科学基金资助项目(30901756);教育部博士点新教师基金资助项目(20090181120100)
详细信息
    作者简介:

    杨丽菲(1987-),女,硕士在读,主要从事放化疗的临床及基础研究

    通信作者:

    丁振宇,E-mail:dingzy333@163.com

  • 中图分类号: R734.2

Prognostic Value of Hemoglobin Level in Elderly Patients with Advanced Lung Cancer Treated with Chemotherapy

  • 摘要: 目的 探讨血红蛋白(HGB)水平对老年晚期NSCLC患者化疗的预后价值。方法 纳入老年NSCLC患者73例,收集患者化疗前HGB水平。HGB水平≤110 g/L为贫血组,否则为正常组。观察两组的近期疗效及远期生存情况。结果 贫血组和正常组患者的基线情况相似(P>0.05)。正常组的中位生存时间较贫血组长,且差异达到有统计学意义的趋势(P=0.137)。经过Cox多因素分析,发现HGB 水平可能是独立预后因素。结论 HGB水平可能对老年晚期NSCLC患者有潜在的预后判断价值。

     

    Abstract: Objective To explore the prognostic value of hemoglobin levels in the elderly lung cancer patients after treatment with chemotherapy. Methods We conducted retrospective cohort study of 73 elderly patients with non-small cell lung cancer (NSCLC). The hemoglobin (HGB) was measured before the start of chemotherapy. Patients with HGB level ≤110 g/L were assigned as the anemia group and others were the normal group. The efficacy and long-term survival were retrieved. Results Those with normal (normal group) or low HGB (anemia group) had similar demographic features(P>0.05). Overall survival of normal group was longer than that of anemia group, and the difference showed a tendency toward statistical significance (P=0.137). Multivariate analysis demonstrated a survival advantage for normal group (P=0.045,HR=0.544,95%CI=0.300-0.985). Conclusion HGB levels have a potential prognostic value for the chemotherapy treatment on elderly advanced NSCLC patients.

     

  • [1] Ding ZY, Zhou L, Liu YM, et al. Safety and effi cacy of paclitaxel liposome for elderly patients with advanced non-small cell lung cancer: a multi-center prospective study[J]. Thoracic Cancer,2013,4(1):14-9.
    [2] Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)[J]. Eur J Cancer,2009,45(2):228-47.
    [3] The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer[J]. J Natl Cancer Inst,1999,91(1):66-72.
    [4] Gridelli C, Perrone F, Gallo C. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the multicenter Italian lung cancer in the Elderly Study (MILES) phase Ⅲ randomized trial[J]. J Natl Cancer Inst,2003,95(5):362-72.
    [5] E Quoix,G Zalcman,JP Oster,et al.Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial[J].Lancet,2011,378(9796): 10 79-88.
    [6] Abe T,Yokoyama A,Takeda K, et al. Randomized phase Ⅲ trial comparing weekly docetaxel(D)-cisplatin(P) combination with triweekly D alone in elderly patients(pts) with advance non-small cell lung cancer(NSCLC): an intergroup tiral of JCOG0803/ WJOG4307L [J]. J Clin Oncol, 2011,29:7509.
    [7] Zheng Z, Chen T, Li X, et al. DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer[J]. N Engl J Med,2007,356(8):800-8.
    [8] Hasenclever D,Diehl V.A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin‘s Disease[J]. N Engl J Med,1998,339(21):1506-14.
    [9] Hoff CM.Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy[J]. Acta Oncol,2012,51(4):419-32.
    [10] Zhang HQ,Wang RB, Yan HJ, et al. Prognostic significance of CYFRA21-1,CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy[J]. Asian Pac J Cancer Prev,2012, 13(1):199-203.
    [11] Walter CJ, Bell LT, Parsons SR, et al. Prevalence and signifi cance of anaemia in patients receiving long-course neoadjuvant chemoradiotherapy for rectal carcinoma[J].Colorectal Dis,2012,15(1):52-6.
    [12] Holgersson G,Sandelin M,Hoye E,et al.Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer[J]. Med Oncol,2012,29(5):3167-82.
    [13] Solal-Céligny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index[J]. Blood,2004,104(5):1258-65.
    [14] Kim WY, Perera S, Zhou B, et al. HIF2α cooperates with RAS to promote lung tumorigenesis in mice[J]. J Clin Invest,2009,119(8): 21 60-70.
计量
  • 文章访问数:  1684
  • HTML全文浏览量:  412
  • PDF下载量:  628
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-03-06
  • 修回日期:  2013-10-09
  • 刊出日期:  2014-05-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭